Document Classification

Section Type: RESULTS

Text: At term-equivalent age, compared with untreated controls, fewer infants treated with recombinant human erythropoietin had abnormal scores for white matter injury (22 % [17/77] vs 36 % [32/88] ; adjusted risk ratio [RR], 0. 58 ; 95 % CI, 0. 35-0. 96), white matter signal intensity (3 % [2/77] vs 11 % [10/88] ; adjusted RR, 0. 20 ; 95 % CI, 0. 05-0. 90), periventricular white matter loss (18 % [14/77] vs 33 % [29/88] ; adjusted RR, 0. 53 ; 95 % CI, 0. 30-0. 92), and gray matter injury (7 % [5/77] vs 19 % [17/88] ; adjusted RR, 0. 34 ; 95 % CI, 0. 13-0. 89).